Jan 16 2026BUSINESS
Wegovy's Strong Start: Novo Nordisk Shares Jump
Novo Nordisk's shares got a nice boost on Friday. They went up by more than 5% after some early reports came out. These reports showed that their new obesity pill, Wegovy, is doing well in the U. S. market. The pill, which is the first of its kind for weight loss, had a good start. But experts say
reading time less than a minute
